Key facts
- This page summarizes Gabriel Loh's Form 3 filing for TITAN PHARMACEUTICALS INC (TTNP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 May 2025, 13:50.
Gabriel Loh - 27 Mar 2025 Form 3 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)
- Reporting relationship
- Director
- Issuer ticker
- TTNP
- Reported as of
- 27 Mar 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Gabriel Loh
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Gabriel Loh filed Form 3 for TITAN PHARMACEUTICALS INC (TTNP) on 05 May 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002066881
Primary reporting owner
Loh Gabriel
- Relationship
- Director
- Address
- C/O TITAN PHARMACEUTICALS, INC., 10 EAST 53RD ST., SUITE 3001, NEW YORK
- Signature
- /s/ Gabriel Loh
- Signature date
- 05 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TTNP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 27 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
No securities are beneficially owned.